Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL

Control

Standard treatment

BIOLOGICAL

Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions

3 doses of 5 million MSC will be administered

BIOLOGICAL

Allogenic fetal mesenchymal stem cells from umbilical cord - six infusions

6 doses of 5 million MSC will be administered

Trial Locations (7)

28223

RECRUITING

Hospital Quironsalud Madrid, Pozuelo de Alarcón

Unknown

RECRUITING

Complejo Hospitalario La Coruña, A Coruña

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Universitario La Paz, Madrid

RECRUITING

Hospital Universitario Carlos Haya, Málaga

RECRUITING

Hospital Vírgen del Rocío, Seville

RECRUITING

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT06270199 - Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia. | Biotech Hunter | Biotech Hunter